View Item 

Show simple item record

LC‐MS/MS isomeric profiling of permethylated N‐glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients
dc.contributor.authorHuang, Yifan
dc.contributor.authorZhou, Shiyue
dc.contributor.authorZhu, Jianhui
dc.contributor.authorLubman, David M.
dc.contributor.authorMechref, Yehia
dc.date.accessioned2017-10-05T18:20:34Z
dc.date.available2018-12-03T15:34:04Zen
dc.date.issued2017-09
dc.identifier.citationHuang, Yifan; Zhou, Shiyue; Zhu, Jianhui; Lubman, David M.; Mechref, Yehia (2017). "LC‐MS/MS isomeric profiling of permethylated N‐glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients." ELECTROPHORESIS 38(17): 2160-2167.
dc.identifier.issn0173-0835
dc.identifier.issn1522-2683
dc.identifier.urihttps://hdl.handle.net/2027.42/138429
dc.description.abstractEarly stage detection and cancer treatment demand the identification of reliable biomarkers. Over the past decades, efforts have been devoted to assess the variation of glycosylation level as well as the glycan structures of proteins in blood or serum, associated with the development and/or progression of several cancers, including liver. Herein, an LC‐MS/MS‐based analysis was conducted to define the glycosylation patterns of haptoglobin glycoprotein derived from sera collected from cirrhotic and hepatocellular carcinoma (HCC) patients. The haptoglobin samples were extracted from serum using an antibody‐immobilized column prior to the release of N‐glycans. A comparison of non‐isomeric and isomeric permethylated glycan forms was achieved using C18 and porous graphitic carbon (PGC) columns, respectively. In the case of C18‐LC‐MS/MS analysis, 25 glycan structures were identified of which 10 sialylated structures were found to be statistically significant between the two cohorts. Also, 8 out of 34 glycan structures identified by PGC‐LC‐MS/MS were found to be statistically significant, suggesting that isomeric distributions of a particular glycan composition were different in abundances between the two cohorts. The glycan isoform patterns distinguished early stage HCC from cirrhotic patients. Both retention times and tandem mass spectra were utilized to determine the specific isomeric glycan structures. All of the glycan isomers, which were statistically significant, were either branch fucosylated or composed of α‐2,6 linked sialic acid moieties. The result of this study demonstrates the potential importance of isomeric separation for defining disease prompted aberrant glycan changes. The levels of several glycan isoforms effectively distinguished early stage HCC from cirrhosis.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherPermethylated glycans
dc.subject.otherCirrhosis
dc.subject.otherHepatocellular carcinoma
dc.subject.otherIsomeric separation
dc.subject.otherLC‐MS/MS
dc.subject.otherGlycans biomarker discovery
dc.titleLC‐MS/MS isomeric profiling of permethylated N‐glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelChemical Engineering
dc.subject.hlbsecondlevelChemistry
dc.subject.hlbsecondlevelMaterials Science and Engineering
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biology
dc.subject.hlbtoplevelEngineering
dc.subject.hlbtoplevelScience
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138429/1/elps6218_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138429/2/elps6218.pdf
dc.identifier.doi10.1002/elps.201700025
dc.identifier.sourceELECTROPHORESIS
dc.identifier.citedreferencede Leoz, M. L., An, H. J., Kronewitter, S., Kim, J., Beecroft, S., Vinall, R., Miyamoto, S., de Vere White, R., Lam, K. S., Lebrilla, C., Dis. Markers 2008, 25, 243 – 258.
dc.identifier.citedreferenceHua, S., An, H. J., Ozcan, S., Ro, G. S., Soares, S., DeVere‐White, R., Lebrilla, C. B., Analyst 2011, 136, 3663 – 3671.
dc.identifier.citedreferenceMichael, C., Rizzi, A. M., J. Chromatogr. A 2015, 1383, 88 – 95.
dc.identifier.citedreferenceTao, S., Huang, Y., Boyes, B. E., Orlando, R., Anal. Chem. 2014, 86, 10584 – 10590.
dc.identifier.citedreferenceBrereton, K. R., Green, D. B., Talanta 2012, 100, 384 – 390.
dc.identifier.citedreferenceHuang, Y., Nie, Y., Boyes, B., Orlando, R., J. Biomol. Tech. 2016, 27, 98 – 104.
dc.identifier.citedreferenceKailemia, M. J., Ruhaak, L. R., Lebrilla, C. B., Amster, I. J., Anal. Chem. 2014, 86, 196 – 212.
dc.identifier.citedreferenceZaia, J., Mass Spectrom. Rev. 2004, 23, 161 – 227.
dc.identifier.citedreferenceAlley, W. R., Jr., Madera, M., Mechref, Y., Novotny, M. V., Anal. Chem. 2010, 82, 5095 – 5106.
dc.identifier.citedreferenceKolarich, D., Windwarder, M., Alagesan, K., Altmann, F., Methods Mol. Biol. 2015, 1321, 427 – 435.
dc.identifier.citedreferenceZhang, Q., Feng, X., Li, H., Liu, B. F., Lin, Y., Liu, X., Anal. Chem. 2014, 86, 7913 – 7919.
dc.identifier.citedreferenceMechref, Y., Kang, P., Novotny, M. V., Methods. Mol. Biol. 2009, 534, 53 – 64.
dc.identifier.citedreferenceKang, P., Mechref, Y., Novotny, M. V., Rapid Commun. Mass Spectrom. 2008, 22, 721 – 734.
dc.identifier.citedreferenceZhou, S., Dong, X., Veillon, L., Huang, Y., Mechref, Y., Anal. Bioanal. Chem. 2016.
dc.identifier.citedreferenceZhu, J., Wu, J., Yin, H., Marrero, J., Lubman, D. M., J. Proteome Res. 2015, 14, 4932 – 4939.
dc.identifier.citedreferenceZhu, J., Lin, Z., Wu, J., Yin, H., Dai, J., Feng, Z., Marrero, J., Lubman, D. M., J. Proteome Res. 2014, 13, 2986 – 2997.
dc.identifier.citedreferenceKang, P., Mechref, Y., Klouckova, I., Novotny, M. V., Rapid Commun. Mass Spectrom. 2005, 19, 3421 – 3428.
dc.identifier.citedreferenceMechref, Y., Hussein, A., Bekesova, S., Pungpapong, V., Zhang, M., Dobrolecki, L. E., Hickey, R. J., Hammoud, Z. T., Novotny, M. V., J. Proteome Res. 2009, 8, 2656 – 2666.
dc.identifier.citedreferenceNie, S., Lo, A., Wu, J., Zhu, J., Tan, Z., Simeone, D. M., Anderson, M. A., Shedden, K. A., Ruffin, M. T., Lubman, D. M., J. Proteome Res. 2014, 13, 1873 – 1884.
dc.identifier.citedreferenceYin, H., Tan, Z., Wu, J., Zhu, J., Shedden, K. A., Marrero, J., Lubman, D. M., J. Proteome Res. 2015, 14, 4876 – 4884.
dc.identifier.citedreferenceZhang, Y., Zhu, J., Yin, H., Marrero, J., Zhang, X. X., Lubman, D. M., J. Proteome Res. 2015, 14, 5388 – 5395.
dc.identifier.citedreferenceFujimura, T., Shinohara, Y., Tissot, B., Pang, P. C., Kurogochi, M., Saito, S., Arai, Y., Sadilek, M., Murayama, K., Dell, A., Nishimura, S., Hakomori, S. I., Int. J. Cancer 2008, 122, 39 – 49.
dc.identifier.citedreferenceOkuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N., Miyoshi, E., Int. J. Cancer 2006, 118, 2803 – 2808.
dc.identifier.citedreferenceMechref, Y., Hu, Y., Desantos‐Garcia, J. L., Hussein, A., Tang, H., Mol. Cell. Proteomics 2013, 12, 874 – 884.
dc.identifier.citedreferenceMechref, Y., Zhou, S., Hu, Y., Hussein, A., Tang, H., Encyclopedia of Analytical Chemistry 2014, Published Online.
dc.identifier.citedreferenceZhou, S., Huang, Y., Dong, X., Peng, W., Vellion, L., Kitagawa, D., Aquino, A., Mechref, Y., Anal. Chem. 2017, 89, 6590 – 6597.
dc.identifier.citedreferencePabst, M., Altmann, F., Anal. Chem. 2008, 80, 7534 – 7542.
dc.identifier.citedreferencePompach, P., Ashline, D. J., Brnakova, Z., Benicky, J., Sanda, M., Goldman, R., J. Proteome Res. 2014, 13, 5561 – 5569.
dc.identifier.citedreferenceIsailovic, D., Kurulugama, R. T., Plasencia, M. D., Stokes, S. T., Kyselova, Z., Goldman, R., Mechref, Y., Novotny, M. V., Clemmer, D. E., J. Proteome Res. 2008, 7, 1109 – 1117.
dc.identifier.citedreferenceFerlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., Parkin, D. M., Int. J. Cancer 2010, 127, 2893 – 2917.
dc.identifier.citedreferenceKamangar, F., Dores, G. M., Anderson, W. F., J. Clin. Oncol. 2006, 24, 2137 – 2150.
dc.identifier.citedreferenceYin, X., Zheng, S. S., Zhang, L., Xie, X. Y., Wang, Y., Zhang, B. H., Wu, W., Qiu, S., Ren, Z. G., Gene 2017, 596, 53 – 88.
dc.identifier.citedreferenceEl‐Serag, H. B., N. Engl. J. Med. 2011, 365, 1118 – 1127.
dc.identifier.citedreferenceLlovet, J. M., Bru, C., Bruix, J., Semin. Liver Dis. 1999, 19, 329 – 338.
dc.identifier.citedreferenceMa, X., Wang, X., Yang, C., Wang, Z., Han, B., Wu, L., Zhuang, L., Anticancer Res. 2016, 36, 6389 – 6398.
dc.identifier.citedreferenceWang, F., Huang, J., Zhu, Z., Ma, X., Cao, L., Zhang, Y., Chen, W., Dong, Y., Cancer Prev. Res. (Phila) 2016, 9, 739 – 749.
dc.identifier.citedreferenceLiu, X., Chi, X., Gong, Q., Gao, L., Niu, Y., Cheng, M., Si, Y., Wang, M., Zhong, J., Niu, J., Yang, W., PLoS One 2015, 10, e0127518.
dc.identifier.citedreferenceCheng, H. T., Chang, Y. H., Chen, Y. Y., Lee, T. H., Tai, D. I., Lin, D. Y., J. Chin. Med. Assoc. 2007, 70, 310 – 317.
dc.identifier.citedreferenceDi Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S., Lee, W. M., Morgan, T. R., Ghany, M. G., Gretch, D. R., J. Hepatol. 2005, 43, 434 – 441.
dc.identifier.citedreferenceDwek, R. A., Chem. Rev. 1996, 96, 683 – 720.
dc.identifier.citedreferenceKhoury, G. A., Baliban, R. C., Floudas, C. A., Sci. Rep. 2011, 1.
dc.identifier.citedreferenceTerao, N., Takamatsu, S., Minehira, T., Sobajima, T., Nakayama, K., Kamada, Y., Miyoshi, E., World J. Gastroenterol. 2015, 21, 3876 – 3887.
dc.identifier.citedreferenceZhao, Y. P., Xu, X. Y., Fang, M., Wang, H., You, Q., Yi, C. H., Ji, J., Gu, X., Zhou, P. T., Cheng, C., Gao, C. F., PLoS One 2014, 9, e94536.
dc.identifier.citedreferenceFeng, X., Zhao, L., Gao, S., Song, X., Dong, W., Zhao, Y., Zhou, H., Cheng, L., Miao, X., Jia, L., Gene 2016, 578, 232 – 241.
dc.identifier.citedreferenceSato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., Taketa, K., Endo, Y., Nagataki, S., N. Engl. J. Med. 1993, 328, 1802 – 1806.
dc.identifier.citedreferenceTaketa, K., Endo, Y., Sekiya, C., Tanikawa, K., Koji, T., Taga, H., Satomura, S., Matsuura, S., Kawai, T., Hirai, H., Cancer. Res. 1993, 53, 5419 – 5423.
dc.identifier.citedreferenceShiraki, K., Takase, K., Tameda, Y., Hamada, M., Kosaka, Y., Nakano, T., Hepatology 1995, 22, 802 – 807.
dc.identifier.citedreferenceLim, T. S., Kim do, Y., Han, K. H., Kim, H. S., Shin, S. H., Jung, K. S., Kim, B. K., Kim, S. U., Park, J. Y., Ahn, S. H., Scand. J. Gastroenterol. 2016, 51, 344 – 353.
dc.identifier.citedreferenceZhou, S., Hu, Y., Mechref, Y., Electrophoresis 2016, 37, 1506 – 1513.
dc.identifier.citedreferenceTsai, T. H., Wang, M., Di Poto, C., Hu, Y., Zhou, S., Zhao, Y., Varghese, R. S., Luo, Y., Tadesse, M. G., Ziada, D. H., Desai, C. S., Shetty, K., Mechref, Y., Ressom, H. W., J. Proteome Res. 2014, 13, 4859 – 4868.
dc.identifier.citedreferenceChovanec, M., Plzak, J., Betka, J., Brabec, J., Kodet, R., Smetana, K., Jr., Oncol. Rep. 2004, 12, 297 – 301.
dc.identifier.citedreferenceHolikova, Z., Hrdlickova‐Cela, E., Plzak, J., Smetana, K., Jr., Betka, J., Dvorankova, B., Esner, M., Wasano, K., Andre, S., Kaltner, H., Motlik, J., Hercogova, J., Kodet, R., Gabius, H. J., APMIS 2002, 110, 845 – 856.
dc.identifier.citedreferenceMondal, G., Chatterjee, U., Chawla, Y. K., Chatterjee, B. P., Glycoconj. J. 2011, 28, 1 – 9.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
elps6218_am.pdf
Size:
1.729MB
Format:
PDF
View/Open
Name:
elps6218.pdf
Size:
891.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.